Research Institute for Complex Problems of Cardiovascular Diseases, Russia Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2015
NCT02734355
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Research Institute for complex issues of cardiovascular diseases | Research Institute for Complex Problems of Cardiovascular Diseases, Russia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Diabetes Mellitus (Phase 4)

Mitral Valve Stenosis (Phase 4)

Myocardial Ischemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7